Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of tardive dyskinesia with aripiprazole.

Literature DB >> 19826893

Treatment of tardive dyskinesia with aripiprazole.

Ricardo S Osorio¹, L Agüera-Ortiz, A Hurtado de Mendoza, I Ramos, T Palomo.

Abstract

Tardive dyskinesia (TD) is a severe and potential irreversible side effect of antipsychotic treatment. Treatment of established TD is often unsuccessful. In this article, we report three cases of psychogeriatric patients who suffered from TD as a side effect of long-term treatment with haloperidol that resolved after switching treatment to aripiprazole. Potential psychopharmacological mechanisms explaining this finding are briefly discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19826893 DOI： 10.1007/s12640-009-9123-0

Source DB: PubMed Journal: Neurotox Res ISSN： 1029-8428 Impact factor: 3.911

21 in total

Review 1. Mechanism of new antipsychotic medications: occupancy is not just antagonism.

Authors: Gerhard Grunder; Arvid Carlsson; Dean F Wong
Journal: Arch Gen Psychiatry Date: 2003-10

2. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.

Authors: Marni J Grant; Ross J Baldessarini
Journal: Ann Pharmacother Date: 2005-10-11 Impact factor: 3.154

3. Improvement in tardive dyskinesia with aripiprazole use.

Authors: James K Witschy; A Scott Winter
Journal: Can J Psychiatry Date: 2005-03 Impact factor: 4.356

Review 4. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

Authors: Howard C Margolese; Guy Chouinard; Theodore T Kolivakis; Linda Beauclair; Robert Miller; Lawrence Annable
Journal: Can J Psychiatry Date: 2005-10 Impact factor: 4.356

5. Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.

Authors:
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2008-03-18 Impact factor: 5.067

6. A case of aripiprazole and tardive dyskinesia.

Authors: C Abbasian; P Power
Journal: J Psychopharmacol Date: 2008-05-30 Impact factor: 4.153

7. Aripiprazole-related tardive dyskinesia.

Authors: Guy Maytal; Michael Ostacher; Theodore A Stern
Journal: CNS Spectr Date: 2006-06 Impact factor: 3.790

8. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.

Authors: A Inoue; S Miki; M Seto; T Kikuchi; S Morita; H Ueda; Y Misu; Y Nakata
Journal: Eur J Pharmacol Date: 1997-02-19 Impact factor: 4.432

Treatment of tardive dyskinesia with aripiprazole.

Review 1. Mechanism of new antipsychotic medications: occupancy is not just antagonism.

2. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.

3. Improvement in tardive dyskinesia with aripiprazole use.

Review 4. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.

5. Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.

6. A case of aripiprazole and tardive dyskinesia.

7. Aripiprazole-related tardive dyskinesia.

8. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.

Review 9. Tardive dyskinesia and new antipsychotics.

10. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.

1. A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up.

2. Tardive dyskinesia: treatment with aripiprazole.

3. Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report.